Related Experiment Videos
Atopic disease in childhood
Michael S Gold1, Andrew S Kemp
1Department of Paediatrics, Adelaide University, Women's and Children's Hospital, North Adelaide, Adelaide, SA 5000, Australia. michael.gold@adelaide.edu.au
The Medical Journal of Australia
|March 22, 2005
Summary
Children with atopy produce IgE antibodies to environmental allergens. Atopic diseases like eczema and asthma result from genetic and environmental factors, with management focusing on allergen avoidance and symptom relief.
Area of Science:
- Pediatric Allergy and Immunology
- Clinical Immunology
Background:
- Atopy, characterized by IgE antibody production to environmental allergens, is common in children.
- Atopic diseases, including eczema, asthma, and rhinoconjunctivitis, are distinct clinical syndromes.
- Not all children with atopy develop clinical disease or symptoms upon allergen exposure.
Observation:
- Genetic and environmental factors interplay in the development of atopic disease.
- Specific IgE antibodies to environmental allergens are detected via skin prick tests or radioallergosorbent testing.
- Interpretation of allergy test results requires correlation with clinical history and further investigations.
Findings:
- Management of atopic disease is often symptomatic.
- Allergen avoidance is a crucial component of managing atopic conditions.
- Immunotherapy is a potential treatment for severe rhinoconjunctivitis in school-aged children.
Implications:
- Research is ongoing to prevent atopic disease in high-risk infants.
- Strategies to hinder disease progression in children with established atopy are actively investigated.
- Understanding the interplay of genetics and environment is key to future interventions.